Provided by Tiger Trade Technology Pte. Ltd.

Illumina

132.89
-1.5700-1.17%
Post-market: 132.70-0.1900-0.14%18:13 EST
Volume:2.20M
Turnover:290.77M
Market Cap:20.31B
PE:24.38
High:133.34
Open:131.75
Low:129.88
Close:134.46
52wk High:155.53
52wk Low:68.70
Shares:152.80M
Float Shares:149.35M
Volume Ratio:0.80
T/O Rate:1.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.45
EPS(LYR):5.45
ROE:33.36%
ROA:8.39%
PB:7.46
PE(LYR):24.38

Loading ...

Illumina Q4 Revenue USD 1,155 Million VS. Ibes Estimate USD 1,094 Million

THOMSON REUTERS
·
Jan 13

Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025

THOMSON REUTERS
·
Jan 13

Illumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026

THOMSON REUTERS
·
Jan 13

Illumina appoints new chief medical officer amid leadership shifts

TIPRANKS
·
Jan 09

Illumina Names Eric Green Chief Medical Officer as Everett Cunningham Departs

Reuters
·
Jan 09

Illumina Appoints DR. Eric Green as Chief Medical Officer

THOMSON REUTERS
·
Jan 09

Illumina to name Eric Green chief medical officer, Endpoints News reports

TIPRANKS
·
Jan 09

Illumina and PREMIA partner to expand clinical access to CGP in Asia

prnewswire
·
Jan 08

Stock Track | Illumina Soars 5.04% Intraday as Grail Spinoff Eases Regulatory Pressure

Stock Track
·
Jan 06

Illumina Is Maintained at Buy by Guggenheim

Dow Jones
·
Jan 06

Should Illumina’s (ILMN) Grail Spinoff to Ease Regulatory Pressure Require Action From Investors?

Simply Wall St.
·
Jan 05

It’s Earnings Warning Season. How to Profit From Others’ Misery

Dow Jones
·
Jan 01

BUZZ-Life sciences and contract research stocks navigate turbulence in 2025

Reuters
·
Dec 31, 2025

Illumina Is Maintained at Hold by Canaccord Genuity

Dow Jones
·
Dec 22, 2025

What Illumina (ILMN)'s MyOme AI Genomics Partnership Means For Shareholders

Simply Wall St.
·
Dec 22, 2025

BUZZ-Jefferies updates ratings on life sciences firms for 2026

Reuters
·
Dec 17, 2025

Illumina Chief Legal Officer Scott M. Davies Reports Sale of Common Shares

Reuters
·
Dec 17, 2025

Illumina to Webcast Presentation at J.P. Morgan Healthcare Conference

Reuters
·
Dec 17, 2025

Illumina Is Maintained at Neutral by JP Morgan

Dow Jones
·
Dec 16, 2025

Illumina Partners with MyOme to Advance AI-Driven Genomic Health Solutions

Reuters
·
Dec 11, 2025